Survival Benefit of Adding Chemotherapy to Intensity Modulated Radiation in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma

• Xuemei Ji ,

  * E-mail: xuemei.ji@yahoo.com (XJ); chxie65@hotmail.com (CX)

  Affiliations Department of Radiation Oncology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China, Department of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, China

  ⨯
• Conghua Xie ,

  * E-mail: xuemei.ji@yahoo.com (XJ); chxie65@hotmail.com (CX)

  Affiliation Department of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, China

  ⨯
• Desheng Hu,

  Affiliation Department of Radiation Oncology, Tumor Hosptal of Hubei Province, Wuhan, China

  ⨯
• Xia Fan,

  Affiliation Department of Radiation and Medical Oncology, Zhongnan Hospital, Wuhan University, Wuhan, China

  ⨯
• Yajuan Zhou,

  Affiliation Department of Radiation Oncology, Tumor Hosptal of Hubei Province, Wuhan, China

  ⨯
• Yingjie Zheng

  Affiliation Department of Radiation Oncology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China

  ⨯